| Literature DB >> 22964723 |
Ana A Weil1, Fahima Chowdhury, Ashraful I Khan, Daniel T Leung, Taher Uddin, Yasmin Ara Begum, Nirod Chandra Saha, Richelle C Charles, Regina C Larocque, Jason B Harris, Edward T Ryan, Firdausi Qadri, Stephen B Calderwood.
Abstract
Vibriocidal antibody is a marker of recent exposure to Vibrio cholerae O1 infection. We examined vibriocidal titers for 1 year after an episode of severe cholera in patients in Dhaka, Bangladesh; 16 of 53 (30%) patients had a fourfold or greater increase in vibriocidal titer between 6 and 12 months after an episode of severe cholera, suggesting reexposure to the organism. Among patients with rises in titers during follow-up, the patients initially infected with serotype Ogawa had earlier rises in titer than the patients initially infected with serotype Inaba. These data and others suggest that an episode of severe cholera protects against symptomatic disease for several years, but reexposure to the organism occurs frequently in an endemic area, with immunological boosts beginning as early as 6 months after severe disease. Repeated exposures to V. cholerae in endemic areas may be a necessary component for long-lasting protection against severe disease.Entities:
Mesh:
Year: 2012 PMID: 22964723 PMCID: PMC3516269 DOI: 10.4269/ajtmh.2012.12-0323
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345